PRKD1 and malignant colon neoplasm: Accordingly, pharmacological inhibition of PKD or PKD2 knockdown in colon cancer cell lines blocked Akt and ERK signaling and suppressed NF-κB activity, leading to G2–M arrest and induction of apoptosis in vitro along with reduced tumor growth in vivo [64].